Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis.

Visentini M, Del Padre M, Colantuono S, Yang B, Minafò YA, Antonini S, Carnovale M, De Santis A, Pulsoni A, De Sanctis GM, Gragnani L, Zignego AL, Fiorilli M, Casato M.

Liver Int. 2019 Apr;39(4):628-632. doi: 10.1111/liv.14053. Epub 2019 Feb 15.

PMID:
30690862
2.

Persistence of Pathogenic B-Cell Clones and Relapse of Cryoglobulinemic Vasculitis in HCV-Cured Patients.

Visentini M, Fiorilli M, Casato M.

Gastroenterology. 2019 Jan;156(1):291. doi: 10.1053/j.gastro.2018.06.094. Epub 2018 Oct 10. No abstract available.

PMID:
30315773
3.

HBV messing with the B-cell genome leads to DLBCL.

Visentini M, Casato M.

Blood. 2018 Jun 14;131(24):2602-2603. doi: 10.1182/blood-2018-05-847525. No abstract available.

4.

Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer.

Visentini M, Quartuccio L, Del Padre M, Colantuono S, Minafò YA, Fiorilli M, De Vita S, Casato M.

Rheumatology (Oxford). 2018 Oct 1;57(10):1870-1871. doi: 10.1093/rheumatology/key157. No abstract available.

PMID:
29868896
5.

DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells.

Camponeschi A, Todi L, Cristofoletti C, Lazzeri C, Carbonari M, Mitrevski M, Marrapodi R, Del Padre M, Fiorilli M, Casato M, Visentini M.

Immunol Lett. 2018 Jun;198:7-11. doi: 10.1016/j.imlet.2018.03.014. Epub 2018 Mar 29.

PMID:
29601939
6.

From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?

Visentini M, Fiorilli M, Casato M.

Expert Rev Hematol. 2017 Aug;10(8):719-727. doi: 10.1080/17474086.2017.1349607. Epub 2017 Jul 13. Review.

PMID:
28675071
7.

Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.

Del Padre M, Todi L, Mitrevski M, Marrapodi R, Colantuono S, Fiorilli M, Casato M, Visentini M.

Blood. 2017 Jul 6;130(1):35-38. doi: 10.1182/blood-2017-03-771238. Epub 2017 May 15.

8.

International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, Antonelli A, Desbois AC, Comarmond C, Gragnani L, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV.

Autoimmun Rev. 2017 May;16(5):523-541. doi: 10.1016/j.autrev.2017.03.004. Epub 2017 Mar 7. Review.

9.

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.

Ramos-Casals M, Zignego AL, Ferri C, Brito-Zerón P, Retamozo S, Casato M, Lamprecht P, Mangia A, Saadoun D, Tzioufas AG, Younossi ZM, Cacoub P; International Study Group of Extrahepatic Manifestations related to HCV (ISG-EHCV).

J Hepatol. 2017 Jun;66(6):1282-1299. doi: 10.1016/j.jhep.2017.02.010. Epub 2017 Feb 20. Review. No abstract available.

PMID:
28219772
10.

Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.

Colantuono S, Mitrevski M, Yang B, Tola J, Carlesimo M, De Sanctis GM, Fiorilli M, Casato M, Visentini M.

Clin Rheumatol. 2017 Mar;36(3):617-623. doi: 10.1007/s10067-017-3552-6. Epub 2017 Jan 22.

PMID:
28111716
11.

Reply.

Zignego AL, Gragnani L, Visentini M, Casato M.

Hepatology. 2017 May;65(5):1771-1772. doi: 10.1002/hep.28977. No abstract available.

PMID:
27943334
12.

Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.

Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, Perez M, Ceccotti G, Colantuono S, Mitrevski M, Stasi C, Del Padre M, Monti M, Gianni E, Pulsoni A, Fiorilli M, Casato M, Zignego AL.

Hepatology. 2016 Nov;64(5):1473-1482. doi: 10.1002/hep.28753. Epub 2016 Aug 29.

PMID:
27483451
13.

International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement.

Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC, Sebastiani M, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV coauthors.

Autoimmun Rev. 2016 Dec;15(12):1145-1160. doi: 10.1016/j.autrev.2016.09.006. Epub 2016 Sep 16. Review.

14.

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, Bruno R, Merli M, Dorival C, Alric L, Jaccard A, Pol S, Carrat F, Ferretti VV, Visco C, Hermine O.

Blood. 2016 Nov 24;128(21):2527-2532. Epub 2016 Sep 7.

15.

Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody.

Visentini M, Pascolini S, Mitrevski M, Marrapodi R, Del Padre M, Todi L, Camponeschi A, Axiotis E, Carlesimo M, De Santis A, Fiorilli M, Casato M.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S28-32. Epub 2016 Jan 20.

PMID:
26811981
16.

Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.

Visentini M, Tinelli C, Colantuono S, Monti M, Ludovisi S, Gragnani L, Mitrevski M, Ranieri J, Fognani E, Piluso A, Granata M, De Silvestri A, Scotti V, Mondelli MU, Zignego AL, Fiorilli M, Casato M.

Autoimmun Rev. 2015 Oct;14(10):889-96. doi: 10.1016/j.autrev.2015.05.013. Epub 2015 May 29.

PMID:
26031898
17.

High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.

Conti V, Leone MC, Casato M, Nicoli M, Granata G, Carlesimo M.

Eur Ann Allergy Clin Immunol. 2015 Mar;47(2):54-7.

18.

The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.

Visentini M, Colantuono S, Granata G, de Santis A, Fiorilli M, Casato M.

Hepatology. 2015 Sep;62(3):975. doi: 10.1002/hep.27600. Epub 2015 Feb 17. No abstract available.

PMID:
25380535
19.

Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.

Zignego AL, Wojcik GL, Cacoub P, Visentini M, Casato M, Mangia A, Latanich R, Charles ED, Gragnani L, Terrier B, Piazzola V, Dustin LB, Khakoo SI, Busch MP, Lauer GM, Kim AY, Alric L, Thomas DL, Duggal P.

Genes Immun. 2014 Oct;15(7):500-5. doi: 10.1038/gene.2014.41. Epub 2014 Jul 17.

20.

Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia.

Biasiotta A, Casato M, La Cesa S, Colantuono S, Di Stefano G, Leone C, Carlesimo M, Piroso S, Cruccu G, Truini A.

J Neurol. 2014 Apr;261(4):725-31. doi: 10.1007/s00415-014-7261-7. Epub 2014 Feb 6.

PMID:
24500496
21.

Peripheral nociceptor sensitization mediates allodynia in patients with distal symmetric polyneuropathy.

Truini A, Biasiotta A, Di Stefano G, La Cesa S, Leone C, Cartoni C, Leonetti F, Casato M, Pergolini M, Petrucci MT, Cruccu G.

J Neurol. 2013 Mar;260(3):761-6. doi: 10.1007/s00415-012-6698-9. Epub 2012 Oct 9.

PMID:
23052607
22.

Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.

Visentini M, Conti V, Cristofoletti C, Lazzeri C, Marrapodi R, Russo G, Casato M, Fiorilli M.

Autoimmun Rev. 2013 Jan;12(3):430-5. doi: 10.1016/j.autrev.2012.08.016. Epub 2012 Aug 23. Review.

PMID:
22940579
23.

Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13.

Visentini M, Cagliuso M, Conti V, Carbonari M, Cibati M, Siciliano G, Cristofoletti C, Russo G, Casato M, Fiorilli M.

Eur J Immunol. 2012 Jun;42(6):1468-76. doi: 10.1002/eji.201142313.

24.

Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection.

Visentini M, Conti V, Cagliuso M, Siciliano G, Scagnolari C, Casato M, Fiorilli M.

J Clin Immunol. 2012 Aug;32(4):729-35. doi: 10.1007/s10875-012-9677-0. Epub 2012 Mar 2.

PMID:
22382878
25.

The V(H)1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21(low) phenotype.

Visentini M, Cagliuso M, Conti V, Carbonari M, Casato M, Fiorilli M.

Blood. 2011 Sep 22;118(12):3440-1; author reply 3442. doi: 10.1182/blood-2011-05-353821. No abstract available.

26.

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.

Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M.

Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5.

PMID:
21570494
27.

Influence of inherited and acquired thrombophilic defects on the clinical manifestations of mixed cryoglobulinaemia.

Casato M, Carlesimo M, Francia A, Timarco C, Antenucci A, Bove M, Martini H, Visentini M, Fiorilli M, Conti L.

Rheumatology (Oxford). 2008 Nov;47(11):1659-63. doi: 10.1093/rheumatology/ken303. Epub 2008 Aug 19.

PMID:
18713771
28.

Efficacy of low-dose rituximab for mixed cryoglobulinemia.

Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M.

Clin Immunol. 2007 Oct;125(1):30-3. Epub 2007 Aug 9.

PMID:
17692572
29.

Different genomic imbalances in low- and high-grade HCV-related lymphomas.

Matteucci C, Bracci M, Barba G, Carbonari M, Casato M, Visentini M, Pulsoni A, Varasano E, Roti G, La Starza R, Crescenzi B, Martelli MF, Fiorilli M, Mecucci C.

Leukemia. 2008 Jan;22(1):219-22. Epub 2007 Aug 9. No abstract available.

PMID:
17690706
30.

Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls.

Bianchettin G, Bonaccini C, Oliva R, Tramontano A, Cividini A, Casato M, Merlini G, Silini E, Mondelli MU.

J Virol. 2007 May;81(9):4564-71. Epub 2007 Feb 21.

31.

Expression of biomarkers of interferon type I in patients suffering from chronic diseases.

Scagnolari C, Bellomi F, Trombetti S, Casato M, Carlesimo M, Bagnato F, Lavolpe V, Bruno R, Millefiorini E, Antonelli L, Girardi E, Turriziani O, Antonelli G.

Clin Exp Immunol. 2007 Feb;147(2):270-6.

32.

Myths, misconceptions and mixed cryoglobulinemia associated with HCV infection.

De Rosa FG, Pucillo LP, Casato M, Agnello V.

Minerva Gastroenterol Dietol. 2002 Dec;48(4):319-29.

PMID:
16491057
33.

Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.

Carbonari M, Caprini E, Tedesco T, Mazzetta F, Tocco V, Casato M, Russo G, Fiorilli M.

J Immunol. 2005 May 15;174(10):6532-9.

34.

Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.

Casato M, Saadoun D, Marchetti A, Limal N, Picq C, Pantano P, Galanaud D, Cianci R, Duhaut P, Piette JC, Fiorilli M, Cacoub P.

J Rheumatol. 2005 Mar;32(3):484-8.

PMID:
15742440
35.

Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation.

Di Stasio E, Bizzarri P, Casato M, Galtieri A, Fiorilli M, Pucillo LP.

Clin Chem Lab Med. 2004;42(6):614-20.

PMID:
15259377
36.

HCV-associated lymphomas.

Fiorilli M, Mecucci C, Farci P, Casato M.

Rev Clin Exp Hematol. 2003 Dec;7(4):406-23. Review.

PMID:
15129650
37.

Occult hepatitis C virus infection in type II mixed cryoglobulinaemia.

Casato M, Lilli D, Donato G, Granata M, Conti V, Del Giudice G, Rivanera D, Scagnolari C, Antonelli G, Fiorilli M.

J Viral Hepat. 2003 Nov;10(6):455-9.

PMID:
14633180
38.

Analysis of the dynamics of cryoaggregation by light-scattering spectrometry.

Di Stasio E, Bizzarri P, Bove M, Casato M, Giardina B, Fiorilli M, Galtieri A, Pucillo LP.

Clin Chem Lab Med. 2003 Feb;41(2):152-8.

PMID:
12667000
39.

Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Scagnolari C, Casato M, Bellomi F, De Pisa F, Turriziani O, Coviello R, Pirro MR, Dianzani F, Antonelli G.

Clin Diagn Lab Immunol. 2003 Jan;10(1):70-7.

40.

Regression of splenic lymphoma after treatment of hepatitis C virus infection.

Agnello V, Mecucci C, Casato M.

N Engl J Med. 2002 Dec 26;347(26):2168-70; author reply 2168-70. No abstract available.

PMID:
12501854
41.

Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia.

De Rosa FG, Pucillo LP, Coviello R, Pirro MR, Fiaschetti P, Candela M, Gabrielli A, Laganà B, Fiorilli M, Casato M.

Hum Immunol. 2002 Sep;63(9):751-7.

PMID:
12175729
42.
43.

Hepatitis C virus and nephrotic syndrome.

De Rosa FG, Laganà B, Bove M, Coviello R, Donnanno S, Fiaschetti P, Fiorilli M, Casato M.

J Hepatol. 2000 Dec;33(6):1027-8. No abstract available.

PMID:
11131444
44.

Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: correlation with levels of antiphospholipid antibodies.

Gentile R, Laganà B, Tubani L, Casato M, Ferri GM, Fedele F.

Ital Heart J. 2000 Jul;1(7):487-92.

PMID:
10933332
45.

Mixed cryoglobulinemia secondary to visceral Leishmaniasis.

Casato M, de Rosa FG, Pucillo LP, Ilardi I, di Vico B, Zorzin LR, Sorgi ML, Fiaschetti P, Coviello R, Laganà B, Fiorilli M.

Arthritis Rheum. 1999 Sep;42(9):2007-11.

46.

Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia.

Di Lullo L, De Rosa FG, Coviello R, Sorgi ML, Coen G, Zorzin LR, Casato M.

Clin Exp Rheumatol. 1998 Jul-Aug;16(4):506. No abstract available.

PMID:
9706438
47.

Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia.

Casato M, Lagana B, Pucillo LP, Quinti I.

N Engl J Med. 1998 May 7;338(19):1386-7. No abstract available.

PMID:
9575053
48.

Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.

De Rosa FG, Di Lullo L, Coviello R, Donnanno S, Laganà B, Casato M.

J Hepatol. 1998 Feb;28(2):355. No abstract available.

PMID:
9514550
49.

Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.

Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, Mazzilli C, Antonelli G, Bonomo L.

Blood. 1997 Nov 15;90(10):3865-73.

50.

HCV infection in a patient with hyper IgM syndrome.

Quinti I, Giovannetti A, Paganelli R, Pucillo LP, Varani AR, Ricci G, Scala E, Pandolfi F, Casato M, Aiuti F.

J Clin Immunol. 1996 Nov;16(6):321-5.

PMID:
8946276

Supplemental Content

Loading ...
Support Center